Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03201068 · ClinicalTrials.gov registry record · NA
Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT03201068: Completed NA study, sponsored by Stanford University.
NCT03201068 is a NA study that has completed, run by Stanford University. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03201068, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study will define the impact of a probiotic supplement on microbiome, immune system, and metabolic syndrome. This study will determine the degree to which a probiotic supplement can 1) improve metabolic markers and metrics of metabolic syndrome, 2) alter microbiota composition and function, 3) impact microbiota metabolites, short-chain fatty acids-potential normalizers of metabolic and immune dysfunction, and 4) regulate immune status and function including reducing chronic, systemic inflammation as assessed by high dimensional immune profiling.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Probiotic supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2017-09-14 |
| Est. Completion | 2018-12-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03201068
The ClinicalTrials.gov registry entry for NCT03201068 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03201068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03201068 about?
NCT03201068 is a clinical study titled "Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome". This study will define the impact of a probiotic supplement on microbiome, immune system, and metabolic syndrome. This study will determine the degree to which a probiotic supplement can 1) improve metabolic markers and metrics of metabolic syndrome, 2) alter microbiota composition and function, 3) ...
What is the current status of trial NCT03201068?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2017-09-14. Estimated completion is 2018-12-04.
What interventions are being tested in trial NCT03201068?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03201068?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.